Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

3.90
-0.0600-1.52%
Volume:1.97M
Turnover:7.84M
Market Cap:438.68M
PE:-0.83
High:4.14
Open:3.98
Low:3.88
Close:3.96
52wk High:12.07
52wk Low:2.10
Shares:112.48M
Float Shares:93.95M
Volume Ratio:0.62
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7089
EPS(LYR):-5.0732
ROE:-65.11%
ROA:-0.45%
PB:1.11
PE(LYR):-0.77

Loading ...

Evolent Health Inc : Keybanc Cuts to Sector Weight From Overweight

THOMSON REUTERS
·
Feb 25

Evolent Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 25

KeyBanc downgrades Evolent Health (EVH) to a Hold

TIPRANKS
·
Feb 25

Evolent Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

Evolent Health Q4 revenue slightly misses analyst expectations

Reuters
·
Feb 25

Evolent posts Q4 net loss attributable to common shareholders of USD 429.1 million (91.6%)

Reuters
·
Feb 25

Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B

TIPRANKS
·
Feb 25

BRIEF-Evolent Health Q4 Revenue USD 468.719 Million Vs. IBES Estimate USD 468.8 Million

Reuters
·
Feb 25

Evolent Health Q4 Revenue USD 468.719 Million VS. Ibes Estimate USD 468.8 Million

THOMSON REUTERS
·
Feb 25

Evolent Health Expects Revenue for FY to Be in the Range of About $2.4 Billion to $2.6 Billion

THOMSON REUTERS
·
Feb 25

Evolent Health Inc: Expects to Deploy About $25 Mln to $35 Mln in Cash for Capitalized Software Development During 2026

THOMSON REUTERS
·
Feb 25

Evolent Health Q4 Adjusted Ebitda Margin 8.1%

THOMSON REUTERS
·
Feb 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 24

Evolent Health Inc. kündigt Veröffentlichung von Finanzzahlen an

Reuters
·
Feb 05

Evolent Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 02

Evolent Health Inc : Btig Cuts Target Price to $10 From $16

THOMSON REUTERS
·
Feb 02

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
Jan 10

Evolent Health price target lowered to $6 from $9.50 at Citi

TIPRANKS
·
Jan 09

Evolent Health Inc : RBC Resumes Coverage With Sector Perform Rating; Target Price $5

THOMSON REUTERS
·
Jan 09

Evolent Health Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jan 06